ADDITIONAL INFO

MK‑677 (Ibutamoren) — Growth Hormone Secretagogue Research Compound

MK‑677 (Ibutamoren) is an investigational growth hormone secretagogue used in laboratory research to study endogenous GH and IGF‑1 stimulation. It mimics ghrelin to activate the pituitary gland, promoting the release of growth hormone (GH) and insulin-like growth factor 1 (IGF‑1). Researchers use MK‑677 to investigate growth hormone signaling, metabolic pathways, and endocrine regulation in preclinical models.

For in‑vitro laboratory research only. Not a drug, food, cosmetic, or veterinary product. Not for human or animal administration.

Product Details

Compound Name: MK‑677 (Ibutamoren)
Net Contents: 12.5 mg/mL sublingual dropper or 12.5 mg capsules
Purity: ≥98% (HPLC tested; Certificate of Analysis available)
Primary Targets: Pituitary GH release, IGF‑1 signaling pathways, ghrelin receptor activation
Manufactured in: GMP-compliant facility
Intended Use: Laboratory research use only — not for human or veterinary use

Storage & Handling

• Store sealed at −20 °C, protected from light and moisture

• Short-term storage: 2–8 °C in sealed vials

• Allow vial to reach room temperature before opening

• Reconstitute under sterile conditions using appropriate buffers

• Avoid repeated freeze–thaw cycles

• Consult SDS for safety and handling guidance

Research Applications

MK‑677 is commonly used in laboratory and preclinical studies to investigate:

• Endogenous growth hormone (GH) and IGF‑1 release

• Pituitary gland activation and ghrelin signaling

• Metabolic pathway regulation

• Endocrine system modulation

• Preclinical models of growth and cellular signaling